Bottom line
FSPHX vs HGHAX: the short answer
FSPHX (Health Care Portfolio) and HGHAX (The Hartford Healthcare Fund) share a meaningful slice of their top holdings — about 50% by weight.
FSPHX is cheaper at 0.62% vs 1.33% — a difference of $71 a year per $10,000 invested.
HGHAX has a front-end sales load of up to 5.5%; the other does not.
Updated Nov 19, 2026
FSPHX vs HGHAX side by side
| FSPHX | HGHAX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Fidelity | Hartford |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.62% | 1.33% |
| Annual cost per $10k | $62 | $133 |
| 10-yr cost on $10k (prospectus) | $774 | $2,063 |
| Max front load | — | 5.5% |
| 12b-1 fee | 0% | 0.25% |
| 1-yr return | +14.4% | — |
| 5-yr return (annualized) | +4.0% | — |
| 10-yr return (annualized) | +9.0% | — |
| Best quarter | +22.2% | +20.9% |
| Worst quarter | −15.0% | −15.7% |
| Net assets (fund) | $5.8B | $772.2M |
| Number of holdings | 152 | 80 |
| Portfolio turnover | 69% | 49% |
| Returns as of | Apr 30, 2026 | — |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | FSPHX | HGHAX | Difference |
|---|---|---|---|
| 2025 | +14.4% | +15.6% | −1.2% |
| 2024 | +4.9% | 0.0% | +4.9% |
| 2023 | +4.1% | +3.8% | +0.3% |
| 2022 | −12.8% | −11.7% | −1.1% |
| 2021 | +11.5% | +10.0% | +1.5% |
| 2020 | +24.4% | +22.6% | +1.8% |
| 2019 | +31.5% | +33.3% | −1.8% |
| 2018 | +7.4% | −3.0% | +10.4% |
| 2017 | +24.0% | +21.6% | +2.4% |
| 2016 | −10.7% | −8.6% | −2.1% |
Source: Fund prospectus bar charts
Holdings overlap
12 of FSPHX's top 25 holdings also appear in HGHAX's top 25.
| Holding | FSPHX | HGHAX |
|---|---|---|
| ELI LILLY and CO | 8.03% | 12.03% |
| Danaher Corp | 6.89% | 2.57% |
| JOHNSON and JOHNSON | 4.91% | 6.75% |
| Thermo Fisher Scientific Inc | 4.33% | 1.58% |
| Unitedhealth Group Inc | 3.49% | 4.74% |
| Boston Scientific Corp | 2.17% | 1.88% |
| Abbvie Inc | 2.03% | 4.21% |
| MERCK and CO INC | 1.60% | 6.00% |
| Cvs Health Corp | 1.29% | 2.84% |
| Cencora Inc | 1.14% | 2.46% |
| Agilent Technologies Inc | 1.10% | 1.54% |
| Edwards Lifesciences Corp | 1.09% | 2.48% |
Source: SEC Form N-PORT
FSPHX top 10
- ELI LILLY and CO — 8.03%
- Danaher Corp — 6.89%
- JOHNSON and JOHNSON — 4.91%
- Thermo Fisher Scientific Inc — 4.33%
- Unitedhealth Group Inc — 3.49%
- Alnylam Pharmaceuticals Inc — 2.40%
- Gilead Sciences Inc — 2.21%
- Boston Scientific Corp — 2.17%
- Ascendis Pharma A/s — 2.17%
- Fidelity Revere Street Trust — 2.17%
HGHAX top 10
- Eli Lilly & Co — 12.03%
- Johnson & Johnson — 6.75%
- Merck & Co Inc — 6.00%
- UnitedHealth Group Inc — 4.74%
- AbbVie Inc — 4.21%
- Elevance Health Inc — 3.00%
- Intuitive Surgical Inc — 2.88%
- CVS Health Corp — 2.84%
- Vertex Pharmaceuticals Inc — 2.64%
- Danaher Corp — 2.57%
FAQ
What is the difference between FSPHX and HGHAX?
Which is cheaper, FSPHX or HGHAX?
Should I own both FSPHX and HGHAX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.